CTRP9 antibody | knockout validation | Aviscera Bioscience A00081-03-100
DOI
//dx.doi.org/10.13070/ko.en.7.2220
Date
2017-03-18

This is a knockout-validated antibody summary, based on the publication "C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Mouse monoclonal IgG

Company: Aviscera Bioscience

Antibody: CTRP9

Catalog number: A00081-03-100

Summary: Mouse monoclonal IgG against recombinant mouse CTRP9 globular form (Val196-Ser333). Reacts with mouse by western blot and ELISA.

Validation Method

Western blot

Sample

Plasma from WT and CTRP9-KO mice. Tissue and cell samples were prepared in lysis buffer containing 1 mM phenylmethylsulfonyl fluoride (Sigma).

Secondary incubation

Horseradish peroxidase-conjugated secondary antibody.

Detection

ECL-Plus system (GE Healthcare).

Figure

Please see Figure 1a in the article [1].

References
  1. Kambara T, Shibata R, Ohashi K, Matsuo K, Hiramatsu-Ito M, Enomoto T, et al. C1q/Tumor Necrosis Factor-Related Protein 9 Protects against Acute Myocardial Injury through an Adiponectin Receptor I-AMPK-Dependent Mechanism. Mol Cell Biol. 2015;35:2173-85 pubmed publisher